Tissue-specific expression of renin-angiotensin system components in IgA nephropathy

American Journal of Nephrology

Volumn 25, Issue 1, 2005, Pages 1-12

  Miyake Ogawa, Chie ^a   Miyazaki, Masanobu ^a   Abe, Katsushige ^a   Harada, Takashi ^a   Ozono, Yoshiyuki ^a   Sakai, Hideto ^b   Koji, Takehiko ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Immunoglobulin A nephropathy; In situ hybridization; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA;

ADULT; ARTICLE; ATROPHY; BOWMAN CAPSULE; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EPITHELIUM CELL; GENE EXPRESSION; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IN SITU HYBRIDIZATION; KIDNEY; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; KIDNEY TUBULE EPITHELIUM; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM CELL; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ANGIOTENSIN II; CASE-CONTROL STUDIES; CHYMASES; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; HUMANS; IN SITU HYBRIDIZATION; KIDNEY GLOMERULUS; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; SERINE ENDOPEPTIDASES;

EID: 17244366310     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083224     Document Type: Article

References (49)

1. Griendling KK, Lassegue B, Alexander RW: Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 1996;36:281-306.
2. Matsusaka T, Hymes J, Ichikawa I: Angiotensin in progressive renal diseases: Theory and practice. J Am Soc Nephrol 1996;7:2025-2043.
3. Hisada Y, Sugaya T, Yamanouchi M, et al: Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 1999:103:627-635.
4. Hollenberg NK: Impact of angiotensin II on the kidney: Does an angiotensin II receptor blocker make sense? Am J Kidney Dis 2000;36:S18-S23.
5. Li J, Zhou C, Yu L, et al: Renal protective effects of blocking the intrarenal renin-angiotensin system. Hypertens Res 1999;22:223-228.
6. Ljutic D, Kes P: The role of arterial hypertension in the progression of non-diabetic glomerular diseases. Nephrol Dial Transplant 2003;18(suppl 5):v28-v30.
7. Ma L, Fogo AB: Role of angiotensin II in glomerular injury. Semin Nephrol 2001;21:544-553.
8. Urata H, Hoffmann S, Ganten D: Tissue angiotensin II system in the human heart. Eur Heart J 1994;15(suppl D):68-78.
9. Urata H, Boehm KD, Philip A, et al: Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993;91:1269-1281.
10. Reilly CF, Tewksbury DA, Schechter NM, et al: Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem 1982;257:8619-8622.
11. Arakawa K, Urata H: Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis. Hypertension 2000;36:638-664.
12. Brain SD, Williams TJ: Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 1988;335:73-75.
13. Wintroub BU, Kaempfer CE, Schechter NM, et al: A human lung mast cell chymotrypsin-like enzyme: Identification and partial characterization. J Clin Invest 1986:77:196-201.
14. Schechter NM, Fraki JE, Geesin JC, et al: Human skin chymotryptic proteinase: Isolation and relation to cathepsin g and rat mast cell proteinase I. J Biol Chem 1983;258:2973-2978.
15. Urata H, Kinoshita A, Misono KS, et al: Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990;265:22348-22357.
16. Akasu M, Urata H, Kinoshita A, et al: Differences in tissue angiotensin II-forming pathways by species and organs in vitro. Hypertension 1998;32:514-520.
17. Arakawa K: Serine protease angiotensin II systems. J Hypertens Suppl 1996;14:S3-S7.
18. Daemen MJ, Urata H: Healing human myocardial infarction associated with increased chymase immunoreactivity. Heart Vessels Suppl 1997;12:113-115.
19. Hoshino F, Urata H, Inoue Y, et al: Chymase inhibitor improves survival in hamsters with myocardial infarction. J Cardiovasc Pharmacol 2003;41(suppl 1):S11-S18.
20. Ihara M, Urata H, Kinoshita A, et al: Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension 1999;33:1399-1405.
21. Toth T, Toth-Jakatics R, Jimi S, et al: Mast cells in rapidly progressive glomerulonephritis. J Am Soc Nephrol 1999;10:1498-1505.
22. Urata H, Nishimura H, Ganten D: Chymase-dependent angiotensin II forming systems in humans. Am J Hypertens 1996;9:277-284.
23. Timmermans PB, Wong PC, Chiu AT, et al: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993:45:205-251.
24. Norwood VF, Craig MR, Harris JM, et al: Differential expression of angiotensin II receptors during early renal morphogenesis. Am J Physiol 1997;272:R662-R668.
25. Lo M, Liu KL, Lantelme P, et al: Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest 1995:95:1394-1397.
26. Siragy HM, Carey RM: The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′, 5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest 1996:97:1978-1982.
27. Stoll M, Steckelings UM, Paul M, et al: The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995:95:651-657.
28. Yamada T, Horiuchi M, Dzau VJ: Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996:93:156-160.
29. Urata H, Kinoshita A, Perez DM, et al: Cloning of the gene and cDNA for human heart chymase. J Biol Chem 1991;266:17173-17179.
30. Bergsma DJ, Ellis C, Kumar C, et al: Cloning and characterization of a human angiotensin II type 1 receptor. Biochem Biophys Res Commun 1992:183:989-995.
31. Martin MM, Su B, Elton TS: Molecular cloning of the human angiotensin II type 2 receptor cDNA. Biochem Biophys Res Commun 1994;205:645-651.
32. Soubrier F, Alhenc-Gelas F, Hubert C, et al: Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 1988;85:9386-9390.
33. Abe K, Miyazaki M, Koji T, et al: Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization. Kidney Int 2001;60:137-146.
34. Furusu A, Miyazaki M, Koji T, et al: Involvement of IL-4 in human glomerulonephritis: An in situ hybridization study of IL-4 mRNA and IL-4 receptor mRNA. J Am Soc Nephrol 1997;8:730-741.
35. Koji T. Brenner RM: Localization of estrogen receptor messenger ribonucleic acid in rhesus monkey uterus by nonradioactive in situ hybridization with digoxigenin-labeled oligodeoxynucleotides. Endocrinology 1993;132:382-392.
36. Kagami S, Border WA, Miller DE, et al: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994:93:2431-2437.
37. Wolf G, Haberstroh U, Neilson EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 1992:140:95-107.
38. Anderson PW, Zhang XY, Tian J, et al: Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells. Kidney Int 1996;50:745-753.
39. Kohno M, Yasunari K, Minami M, et al: Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin. J Am Soc Nephrol 1999;10:2495-2502.
40. Higueruelo S, Romero R: Angiotensin II requires PDGF-BB to induce DNA synthesis in rat mesangial cells cultured in an exogenous insulin-free medium. Nephrol Dial Transplant 1997;12:694-700.
41. Essig M, Dussaule JC, Vandermeersch S, et al: Modulation by angiotensin II of endothelial cell control of DNA synthesis in human mesangial cells. Nephron 1997;75:303-309.
42. Gomez-Garre D, Ruiz-Ortega M, Ortego M, et al: Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 1996;27:885-892.
43. Bakris GL, Re RN: Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am J Physiol 1993;264:F937-F942.
44. Pimentel JL Jr, Martinez-Maldonado M, Wilcox JN, et al: Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int 1993;44:390-400.
45. Ishidoya S, Morrissey J, McCracken R, et al: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 1995;47:1285-1294.
46. Gomez-Garre D, Largo R, Tejera N, et al: Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: Role of angiotensin II and endothelin-1. Hypertension 2001;37:1171-1178.
47. Murakami M, Matsuda H, Kubota E, et al: Role of angiotensin II generated by angiotensin converting enzyme-independent pathways in canine kidney. Kidney Int Suppl 1997;63:S132-S135.
48. Kakuchi J, Ichiki T, Kiyama S, et al: Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 1995:47:140-147.
49. Suzuki H, Yamamoto T, Ikegaya N, et al: Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression. Am J Physiol Renal Physiol 2004;286:F267-F277.